LI
JAZZ icon

Leap Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Leap Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$221K Buy
+2,000
New +$221K 0.15% 272

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Leap Investments's JAZZ Position: Q2 2020 in Review

Leap Investments opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2020: 2,000 shares worth $221K. The stake represents 0.15% of the portfolio and ranks #272 among its holdings.

384 funds tracked by Wall St. Rank hold JAZZ as of Q2 2020.

  • Leap Investments held 2,000 shares of Jazz Pharmaceuticals worth $221K as of Q2 2020.
  • Jazz Pharmaceuticals was a new Leap Investments position in Q2 2020.
  • Jazz Pharmaceuticals made up 0.15% of Leap Investments's portfolio in Q2 2020, its #272 holding.
  • 384 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.